Law360, New York (October 23, 2009) -- EU antitrust regulators have cleared Merck & Co.’s proposed $41.1 billion acquisition of Schering-Plough Corp., a move that will make it the second-largest prescription drug company in the world.
The European Commission said Friday that the proposed deal would not “significantly impede effective competition” in Europe....
